Michel Dreano
Chief Business Officer
Bussiness Management
Relief Therapeutics
Switzerland
Biography
Dr Michel Dreano, born in 1957, is a French citizen. He got a PhD in Molecular Virology at the Institut Pasteur/University Paris VII and a PhD in Molecular and Cellular Biology at the University of Burgundi (France). He joined the Battelle Memorial Institute in Geneva in 1983 where he headed a group involved in the production of recombinant proteins. He moved to Serono International SA in 1989 where he operated as a drug developer and then as a project/alliance manager. In this context, he managed many strategic collaborations and partnerships with academic institutions, research contract organizations, biotechs or large pharmaceutical organizations. In 2007 after the acquisition of Serono International SA by Merck KGaA, Dr Michel Dreano pursued the management of international research projects and integrated the business development department. In 2012, Dr Michel Dreano created an independent consulting company specialized in the management of multidiplinary and cross-national R&D projects. He also participated in the creation of a not-for-profit Foundation, ReMedys, where he serves as an executive member of the Board of Directors. Finally, Dr Michel Dreano is one of the three founders of Relief Therapeutics SA. In the later company he was an active managing partner and operated as Chairman/President.
Research Interest
Bussiness Mangaement and Development
